Results 151 to 160 of about 2,691 (207)

Treatment of Ochronotic Osteoarthropathy and the Evaluation of Selected Lower Limb Muscle Properties, Including the Patellar Tendon: A Case Report and Mini Literature Review. [PDF]

J Clin Med
Jarecki J, Tomczyk-Warunek A, Posturzyńska A, Warda E, Waśko M, Arciszewski K, Tomaszewska E, Muszyński S, Bieniaś J, Ostapiuk M, Skrzypek T, Gągała J.   +11 more
europepmc   +1 more source

Diffuse Facial Leukoderma Secondary to Localized Use of Hydroquinone. [PDF]

Cureus
Artz C, Masood M, Mohammad TF.
europepmc   +1 more source

Biochemical Discovery of Homogentisic Acid Pigment in an Ochronotic Egyptian Mummy [PDF]

, 1979
Lee, Sandra L., Milgram, James W., Rogers, Frank, Stenn, Frederick F., Veis, Arthur, Weigand, Raymond J.   +5 more
core   +1 more source

First Documented Hip Replacement in a Palestinian Patient with Ochronotic Alkaptonuria Arthropathy: A Case Report. [PDF]

J Orthop Case Rep
Shalalfa S, Shalalfa N, Azarabadi JM, Barakat AN.   +3 more
europepmc   +1 more source

Avulsive Achilles Tendon Rupture in a Patient With Alkaptonuria: A Case Report. [PDF]

Cureus
Fabião L, França G, Cunha A, S Pereira B, Esteves N.   +4 more
europepmc   +1 more source

Alkaptonuria: a rare disease with multiorgan manifestation and a long-awaited diagnosis. [PDF]

BMJ Case Rep
Gundersen AD, Hornemann Borg M, Løkke A, Hilberg O.   +3 more
europepmc   +1 more source

Surgical management of calcific valvular and coronary disease in a patient with alkaptonuria: a case report. [PDF]

Eur Heart J Case Rep
Boyd RM, Bharadwaj SN, Fagan A, Mehta CK.   +3 more
europepmc   +1 more source

Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trial. [PDF]

Sci Rep
Ghasemiyeh P, Haghighi NF, Dastgheib L, Ranjbar S, Mohammadi-Samani S.   +4 more
europepmc   +1 more source

Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial Melasma. [PDF]

Dermatol Ther (Heidelb)
Passeron T, Kerob D, Le Dantec G, Demessant-Flavigny AL, do Nascimento AR, Moura R, Salah S, Feiges M, Fernandez E, Alexis A.   +9 more
europepmc   +1 more source